Evidence map›Paper›PMID 23762496›Full record

ArticlePloS one2013

Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China.

Zhiyuan Liu, Wei Li, Jie Wang, Jian Pan, Shipeng Sun, Yanhua Yu, Bing Zhao, Yuzhi Ma, Tingju Zhang, Jie Qi and 2 more

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Multidrug-resistant mammary pathogenicFrontiers in microbiology · 2026
    Article
  2. First Detection ofAntibiotics (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Molecular Characterization of KPC-2-ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Corrigendum: First Report of Coexistence ofFrontiers in microbiology · 2021
    Article
  9. First Report of Coexistence ofFrontiers in microbiology · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. First Report of Complete Sequence of aFrontiers in cellular and infection microbiology · 2016
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhiyuan LiuGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, PR China.
Wei Li
Jie Wang
Jian Pan
Shipeng Sun
Yanhua Yu
Bing Zhao
Yuzhi Ma
Tingju Zhang
Jie Qi
Guijian Liu
Fengmin Lu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New Delhi metallo-β-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat due to its extended hydrolysis of β-lactams including carbapenems. In this study, we identified the first confirmed clinical isolate of Escherichia coli BJ01 harboring bla(NDM-1) in China. The isolate is highly resistant to all tested antimicrobials except polymyxin. bla(NDM-1), bla(CTX-M-57), and bla TEM-1 were identified in the isolate. bla(NDM-1) was transferable to E. coli EC600 and DH5α in both plasmid conjugation experiments and plasmid transformation tests. BJ01 was identified as a new sequence type, ST224, by multilocus sequence typing. Analysis of genetic environment shows complex transposon-like structures surrounding the bla NDM-1 gene. Genetic analysis revealed that the region flanking bla(NDM-1) was very similar to previously identified NDM-positive Acinetobacter spp. isolated in China. The findings of this study raise attention to the emergence and spread of NDM-1-carrying Enterobacteriaceae in China.

Indexed as

Agedbeta-LactamasesBlotting, SouthernCarbapenemsChinaConjugation, GeneticDNA, BacterialDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsPolymerase Chain ReactionTransformation, Bacterialbeta-lactamase NDM-1beta-LactamasesCarbapenemsDNA, Bacterial

Identifiers

PMID23762496
PMCPMC3677923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.